Starting a vivitrol treatment program is one of the most consequential decisions you’ll make in recovery, and the programs offering it aren’t all built the same. Knowing what to ask before you commit separates a program that genuinely supports your recovery from one that administers a monthly injection and calls it treatment.
What Vivitrol Actually Does (and Doesn’t Do)
A pivotal multi-site clinical trial funded by Alkermes found that extended-release naltrexone (the active ingredient in Vivitrol) reduced opioid relapse rates by 90% compared to placebo during the treatment period. That number sounds remarkable, and the mechanism behind it is straightforward: naltrexone binds to opioid receptors and blocks them completely, so opioids produce no euphoria and alcohol produces significantly blunted cravings. Unlike methadone or buprenorphine, it does not activate those receptors at all. There’s no substitute substance, no partial effect. The reward signal simply disappears.
What that doesn’t mean is equally worth understanding. Vivitrol does not address the trauma, unresolved grief, or co-occurring mental health conditions that typically underlie addiction. It doesn’t restructure thought patterns, rebuild relationships, or teach coping skills. And it requires complete detoxification before the first injection, without exception. If you contact a program about how naltrexone works in opioid recovery, the quality of their explanation will tell you a great deal about how seriously they take the clinical side of care. Ask them directly: what does Vivitrol treat, and what does it not treat?
The One Non-Negotiable Before Your First Injection
The FDA medication guide for Vivitrol and SAMHSA clinical guidelines are unambiguous on this point: administering naltrexone before opioids have fully cleared the system causes precipitated withdrawal. This is not ordinary withdrawal. It is severe, acute, and rapid-onset, and it can be dangerous. The standard clearance window is 7 to 10 days opioid-free for heroin and short-acting prescription opioids. For methadone, that window extends significantly, often two weeks or more, because methadone accumulates in tissue and clears slowly. For alcohol use disorder, medically supervised detox must precede the injection because alcohol withdrawal carries its own life-threatening risks, including seizure.
The question to ask every program is not “how soon can I start?” The question is: “How do you confirm I’m fully detoxed before the injection?” A medically sound program will describe a specific protocol, typically a naloxone challenge test or confirmed urine screening, administered by a physician. If a program gives a vague answer, skips this question, or suggests the timeline is flexible based on how you feel, keep looking. That answer is a clinical standard, not a preference.
Five Questions to Ask Any Vivitrol Program Before You Commit
How Do You Handle the Detox Phase?
A 2017 study published in the New England Journal of Medicine comparing extended-release naltrexone to buprenorphine-naloxone in opioid use disorder treatment found that the induction phase, specifically the transition from opioid dependence to the first naltrexone injection, was the highest-risk period in the entire treatment course. Patients who didn’t complete detox before induction were significantly more likely to drop out. That finding points to something programs often gloss over: the handoff between detox and Vivitrol induction is where people fall through the cracks.
Ask whether the program manages detox in-house or refers you elsewhere. If they refer out, ask who coordinates the transition and how they confirm readiness before the injection. The strongest programs use the same clinical team across both phases. Get that answer in writing before you agree to anything.
What Happens Between Injections?
A 2012 randomized controlled trial by Krupitsky and colleagues, published in The Lancet, found that extended-release naltrexone significantly outperformed placebo, but the outcomes were meaningfully better when behavioral counseling was integrated alongside the medication. Vivitrol is a monthly injection. That means 29 days between doses when the pharmacology is doing its job, but the psychological and behavioral dimensions of recovery are entirely up to what the program offers around it. That gap is where relapse happens.
Ask for a written weekly schedule of services, not a verbal description. Individual therapy, group sessions, case management, and peer support are all distinct offerings. A program that describes “comprehensive support” without being able to show you a schedule is telling you something. For a broader picture of how medication fits within a structured recovery plan, reviewing what a full medication-assisted treatment program involves can help you benchmark what you’re being offered.
How Do You Address Co-Occurring Mental Health Conditions?
SAMHSA’s 2022 National Survey on Drug Use and Health found that among adults with opioid use disorder, more than 50% also met criteria for at least one co-occurring mental health condition, most commonly depression, anxiety, PTSD, or bipolar disorder. Untreated mental illness doesn’t pause because Vivitrol is blocking opioid receptors. It remains one of the primary drivers of relapse even when the pharmacological piece is in place.
Ask whether the program employs licensed mental health clinicians on-site and whether dual-diagnosis treatment is woven into the standard schedule. “We can refer you to a therapist” is not the same as integrated care. A program that treats your addiction separately from your mental health is treating half the problem.
What Are Your Staff’s Clinical Credentials?
NAATP quality benchmarks and SAMHSA’s treatment improvement protocols both identify clinical staffing as a core indicator of program quality. There is a meaningful difference between a program staffed by board-certified addiction medicine physicians and licensed therapists versus one that relies primarily on peer coaches and unlicensed counselors. Both peer support and lived experience matter in recovery. Neither replaces licensed clinical judgment.
Ask specifically: who administers the Vivitrol injection, and what are their credentials? Who is responsible for your psychiatric care, and are they licensed? Both questions deserve a specific name and a specific credential, not a general answer about the team.
What Does the Program Cost, and What Is Included?
Vivitrol carries a list price of approximately $1,800 to $2,000 per injection as of recent pricing data, and that figure does not include the clinical visit, counseling sessions, lab work, or housing if the program is residential. Private-pay addiction treatment pricing varies significantly, and “all-inclusive” is a term that means different things at different programs.
Request a complete itemized fee schedule in writing before signing anything. Ask specifically whether therapy sessions, lab tests, and the injections themselves are bundled into one rate or billed separately. A program that resists providing that breakdown in writing is worth scrutinizing before you commit financially.
Red Flags That Tell You to Walk Away
The research covered above translates into a short list of concrete warning signs. A program that offers Vivitrol without a medically supervised detox protocol is skipping the step most likely to cause you harm. A program that cannot name the licensed clinician responsible for your psychiatric care has a gap in its clinical structure. A program that provides no structured programming between injections is offering medication, not treatment. And a program that resists giving itemized pricing is signaling something about how it operates under pressure.
Treat any defensiveness about these questions as diagnostic. A strong program answers them readily because it’s already doing the work. Resistance to transparency is not a communication style. It’s information.
What a Strong Vivitrol Program Actually Looks Like
The American Society of Addiction Medicine (ASAM) criteria for medication-assisted treatment outline a clear progression: medically supervised detox, confirmed opioid-free status via naloxone challenge or urine screening, first injection administered by a physician, and ongoing behavioral therapy running concurrently with the monthly injection schedule. Research on behavioral therapy combinations consistently shows that cognitive behavioral therapy and contingency management produce the strongest outcomes alongside MAT. Relapse protocols, meaning a clear clinical plan for what happens if relapse occurs, should be part of the structure from the start, not an afterthought.
For opioid use disorder specifically, understanding the full landscape of medication-based treatment options helps you evaluate whether Vivitrol is the right fit for your situation, or whether a different approach, like buprenorphine induction, better matches your clinical picture. Ask any program to walk you through exactly what happens from intake to the 90-day mark. A well-designed program can do that in ten minutes. If they can’t, the structure isn’t there.
It’s also worth noting that Vivitrol is one tool, not a complete plan. At programs that integrate MAT into a broader clinical framework, the medication supports the therapeutic work rather than replacing it. That pairing, medication plus structured mental health support, is what the evidence consistently points to.
How to Use This Week to Move Forward
Write down the five questions from this article. Call one program today, not to enroll, but to ask them. You’re not committing to anything. You’re collecting data. The quality of a program’s answers to these questions is the most reliable signal available before you walk through the door.
A program that can tell you exactly how it confirms detox completion, name the clinician who administers the injection, show you a weekly schedule, describe its dual-diagnosis approach, and hand you an itemized fee sheet without hesitation is demonstrating clinical seriousness. That’s what you’re listening for. Let the answers do the sorting.